Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
November 30, 2023
WORKING PAPERS
November 27, 2023
TESTIMONY
November 24, 2023
CGD NOTES
December 04, 2023
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
BRIEFS
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
BRIEFS
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
CASE STUDIES
May 18, 2023
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
CASE STUDIES
May 18, 2023
Antimicrobial resistance (AMR) poses a threat to global health security worldwide, and India carries one of the largest burdens of drug-resistant pathogens. The widespread misuse and overuse of antimicrobials is a major cause of the emergence and spread of resistant microorganisms. This study assess...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
TESTIMONY
December 13, 2022
On December 13th 2022, CGD Senior Fellow Prashant Yadav appeared before the House Foreign Affairs Subcommittee on International Development, International Organizations, and Global Corporate Social Impact at a hearing titled “Modernizing International Development Assistance: Opportunities and Challe...
